Search Results for "days"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for days. Results 1611 to 1620 of 1849 total matches.
Spironolactone for Heart Failure
The Medical Letter on Drugs and Therapeutics • Sep 10, 1999 (Issue 1061)
for this indication. The cost of 25 mg of the drug daily for 30 days would be $11.83 for the
generic or $13.81 ...
Spironolactone, an aldosterone receptor antagonist, has been FDA-approved for many years for treatment of edema, hypertension and primary hyperaldosteronism. Recently, it was reported to improve morbidity and mortality in patients with severe heart failure.
Quinupristin/Dalfopristin
The Medical Letter on Drugs and Therapeutics • Nov 19, 1999 (Issue 1066)
). The cost to the pharmacist for 10 days’ treatment with 7.5
mg/kg q8h in a 65-kg patient would be $3,093.84 ...
Quinupristin and dalfopristin, two streptogramin antibacterials marketed in a 30:70 combination as Synercid, have received accelerated approval from the FDA for intravenous treatment of bacteremia and life-threatening infection....
Exemestane For Advanced Breast Cancer
The Medical Letter on Drugs and Therapeutics • Apr 17, 2000 (Issue 1076)
for 30 days’ treatment according to wholesale (AWP) prices in Drug Topics Red Book Update, April 2000 ...
The FDA has approved exemestane, an aromatase inhibitor, for the treatment of postmenopausal women with advanced breast cancer that has progressed during treatment with tamoxifen.
A New Snake Antivenom
The Medical Letter on Drugs and Therapeutics • Jun 25, 2001 (Issue 1107)
the package insert states that the antivenom should be refrigerated, it has been safe after 60 days’ exposure ...
CroFab, an antigen-binding-fragment (Fab) antivenom of ovine origin, has been approved by the FDA for treatment of North American rattlesnake envenomation.
Drug-eluting Stents
The Medical Letter on Drugs and Therapeutics • Mar 17, 2003 (Issue 1152)
(PW Serruys et al, Circulation 2002; 106:798). The long-term effects of a
30-day local exposure ...
Most angioplasty procedures for coronary artery disease now include placement of stents, which have improved both short- and long-term success rates. The main limitation is restenosis, which occurs in about 25% of patients. Drug-eluting stents intended to reduce the incidence of restenosis have been approved for use in Europe, but not yet in the US.
Olanzapine/Fluoxetine (Symbyax) for Bipolar Depression
The Medical Letter on Drugs and Therapeutics • Mar 15, 2004 (Issue 1178)
with fluoxetine (in doses of 6 and 25 mg, 6 and 50 mg, or 12 and 50 mg per day) in a flexible
dosing schedule ...
The fixed-dose combination of olanzapine and fluoxetine (Symbyax - Lilly) has been approved by the FDA for treatment of depressive episodes associated with bipolar disorder. Olanzapine alone (Zyprexa), which is mainly used as an antipsychotic (Medical Letter 2003; 45:102), is FDA-approved for treatment of acute manic episodes and for maintenance treatment of bipolar disorder. Fluoxetine alone (Prozac, and others), which is mainly used as an antidepressant (Medical Letter 2003; 45:93), has no specific approval for use in bipolar...
Botulinum Toxin (Botox) for Axillary Hyperhidrosis
The Medical Letter on Drugs and Therapeutics • Sep 13, 2004 (Issue 1191)
% of those
injected with placebo. The median duration of the
response was 201 days.
2
ADVERSE EFFECTS ...
Botulinum toxin type A (Botox - Allergan) has been approved by the FDA for treatment of severe underarm sweating ("primary axillary hyperhidrosis"). Injected into the skin, botulinum toxin decreases sweating by causing chemical denervation of the sweat gland.
In Brief: Melamine
The Medical Letter on Drugs and Therapeutics • Oct 20, 2008 (Issue 1297)
from studies in
rats, a tolerable daily intake of 0.63 mg/kg/day.
1
However, the combination of melamine ...
Melamine present in infant formula and other milk products has been associated with widespread illness and some deaths among infants in China. It was also identified in pet food sold in North America after a large number of pets became ill and some died. In both the infants and the pets, renal injury appeared to be the cause.1Melamine (C3H6N6) is a heterocyclic compound, two-thirds nitrogen by weight, that is slightly soluble in water. When combined with formaldehyde, it forms melamine resin, which has a wide variety of industrial applications including the manufacturing of kitchenware,...
In Brief: Different Diets
The Medical Letter on Drugs and Therapeutics • Mar 23, 2009 (Issue 1308)
of 750 kcal
per day. Most participants lost weight in the first 6
months and regained some thereafter ...
A recent article in the New England Journal of Medicine confirms something that others, including The Medical Letter (Treat Guidel Med Lett 2008; 6:23), have been saying for years: no particular combination of protein, carbohydrate and fat in the diet offers any advantage in losing weight. This randomized 2-year trial followed 800 overweight and obese subjects on low fat/average protein, low fat/high protein, high fat/average protein, and high fat/high protein diets. Carbohydrate intake varied from 35% (in the high fat/high protein diet) to 65% (in the low fat/average protein diet). All...
PDE5 Inhibitors for Erectile Dysfunction
The Medical Letter on Drugs and Therapeutics • Feb 06, 2012 (Issue 1383)
day.
2. Patients should be on stable alpha-blocker therapy before starting treatment with a PDE5 ...
Sildenafil (Viagra), tadalafil (Cialis) and vardenafil (Levitra, Staxyn) have become the standard treatment for erectile dysfunction. Head-to-head comparisons of these agents are still lacking, but some differences between them and new recommendations for their dosing (see Table 2) are worth noting.